These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 19100517

  • 1. Deletion 15q as the sole abnormality in acute myeloid leukemia: report of three cases and review of the literature.
    Lu G, Yin CC, Medeiros LJ, Abruzzo LV.
    Cancer Genet Cytogenet; 2009 Jan 15; 188(2):118-23. PubMed ID: 19100517
    [Abstract] [Full Text] [Related]

  • 2. del(6)(p23) in two cases of de novo AML--a new recurrent primary chromosome abnormality.
    Anwar Iqbal M, Al-Omar HM, Owaidah T, Al-Humaidan H, Bhuiyan ZA, Sahovic E.
    Eur J Haematol; 2006 Sep 15; 77(3):245-50. PubMed ID: 16856925
    [Abstract] [Full Text] [Related]

  • 3. Deletion of chromosome arm 15q in a case of minimally differentiated hypoplastic AML-M0.
    Fujieda A, Masuya M, Kitano S, Miyazaki K, Yazaki A, Sugimoto Y, Usui E, Miyata E, Shibasaki T, Yamamura K, Ohishi K, Nishii K, Nakase K, Takeuchi T, Katayama N.
    Cancer Genet Cytogenet; 2008 Jul 15; 184(1):57-61. PubMed ID: 18558291
    [Abstract] [Full Text] [Related]

  • 4. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
    Haferlach C, Bacher U, Schnittger S, Alpermann T, Zenger M, Kern W, Haferlach T.
    Genes Chromosomes Cancer; 2012 Apr 15; 51(4):328-37. PubMed ID: 22162288
    [Abstract] [Full Text] [Related]

  • 5. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M, Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C.
    Cancer Genet Cytogenet; 2004 Nov 15; 155(1):47-56. PubMed ID: 15527902
    [Abstract] [Full Text] [Related]

  • 6. Deletion of chromosome arm 15q and hitherto unreported duplication of del(15q) in myeloid disorders.
    Saunders K, Williams Y, Aldouri M, Telford N, Czepulkowski B.
    Cancer Genet Cytogenet; 2004 Jun 15; 151(2):146-51. PubMed ID: 15172752
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J, Zemanová Z, Ransdorfová S, Sindelárová L, Sisková M, Neuwirtová R, Cermák J, Michalová K.
    Cancer Genet Cytogenet; 2005 Jul 15; 160(2):188-92. PubMed ID: 15993278
    [Abstract] [Full Text] [Related]

  • 8. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
    Li TY, Xue YQ, Wu YF, Pan JL, Liu DD, Gong SL.
    Zhonghua Yi Xue Za Zhi; 2004 May 02; 84(9):732-5. PubMed ID: 15200909
    [Abstract] [Full Text] [Related]

  • 9. Acute myelogenous leukemia with tetrasomy 8 is a disease with a poor prognosis.
    Tsirigotis P, Papageorgiou S, Abatzis D, Athanatou S, Girkas C, Pappa V, Pangalos C, Papageorgiou E, Dervenoulas J, Raptis S.
    Cancer Genet Cytogenet; 2005 Aug 02; 161(1):78-81. PubMed ID: 16080962
    [Abstract] [Full Text] [Related]

  • 10. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB, Zheng JE, Gu JX, Yao JX, Yang J, Liu J, Li XQ, He YL, Yu JM, Wei J, Liu ZP, Huang SA.
    Ai Zheng; 2005 Jun 02; 24(6):667-71. PubMed ID: 15946475
    [Abstract] [Full Text] [Related]

  • 11. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y, Xu W, Liu Q, Pan J, Qiu H, Wang R, Qiao C, Jiang Y, Zhang S, Fan L, Zhang J, Shen Y, Xue Y, Li J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct 02; 25(5):579-82. PubMed ID: 18841577
    [Abstract] [Full Text] [Related]

  • 12. Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome.
    Glassman AB, Hayes KJ.
    Ann Clin Lab Sci; 2003 Oct 02; 33(3):285-8. PubMed ID: 12956443
    [Abstract] [Full Text] [Related]

  • 13. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T, Nilsson L, Lenhoff S, Rylander L, Astrand-Grundström I, Strömbeck B, Höglund M, Turesson I, Westin J, Mitelman F, Jacobsen SE, Johansson B.
    Genes Chromosomes Cancer; 2004 Nov 02; 41(3):223-31. PubMed ID: 15334545
    [Abstract] [Full Text] [Related]

  • 14. Cytogenetic manifestation of chromosome 11 duplication/amplification in acute myeloid leukemia.
    Sárová I, Brezinová J, Zemanová Z, Izáková S, Lizcová L, Malinová E, Berková A, Cermák J, Maaloufová J, Nováková L, Michalová K.
    Cancer Genet Cytogenet; 2010 Jun 02; 199(2):121-7. PubMed ID: 20471515
    [Abstract] [Full Text] [Related]

  • 15. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J, Zemanová Z, Ransdorfová S, Pavlistová L, Babická L, Housková L, Melichercíková J, Sisková M, Cermák J, Michalová K.
    Cancer Genet Cytogenet; 2007 Feb 02; 173(1):10-6. PubMed ID: 17284364
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia.
    Fröhling S, Kayser S, Mayer C, Miller S, Wieland C, Skelin S, Schlenk RF, Döhner H, Döhner K, AML Study Group Ulm.
    Haematologica; 2005 Feb 02; 90(2):194-9. PubMed ID: 15710571
    [Abstract] [Full Text] [Related]

  • 17. Acute myelomonocytic leukemia (M4) with eosinophilia: problems concerning chromosome 16 abnormality.
    Harth H, Pees H, Zankl H.
    Cancer Genet Cytogenet; 1986 Oct 02; 23(2):127-33. PubMed ID: 3463402
    [Abstract] [Full Text] [Related]

  • 18. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M, Hélias C, Struski S, Perrusson N, Uettwiller F, Mozziconacci MJ, Lafage-Pochitaloff M, Dastugue N, Terré C, Brizard F, Cornillet-Lefebvre P, Mugneret F, Barin C, Herry A, Luquet I, Desangles F, Michaux L, Verellen-Dumoulin C, Perrot C, Van den Akker J, Lespinasse J, Eclache V, Berger R, Groupe Francophone de Cytogénétique Hématologique.
    Cancer Genet Cytogenet; 2007 Jul 01; 176(1):1-21. PubMed ID: 17574959
    [Abstract] [Full Text] [Related]

  • 19. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B, Rödjer S, Westin J.
    Ann Hematol; 2008 Jun 01; 87(6):467-74. PubMed ID: 18351338
    [Abstract] [Full Text] [Related]

  • 20. A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia.
    Potenza L, Sinigaglia B, Luppi M, Morselli M, Saviola A, Ferrari A, Riva G, Zucchini P, Giacobbi F, Emilia G, Temperani P, Torelli G.
    Cancer Genet Cytogenet; 2004 Mar 01; 149(2):164-8. PubMed ID: 15036893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.